Prevalence and correlates of past 30-day dual-vaping of nicotine and cannabis among adolescents in five New England states.
Liu J, Winickoff JP, Hanby E, Rees V, Emmons KM, Tan AS.
Drug Alcohol Depend. 2024 Jan 01. 254:111055. PMID: 38071894
Senior Lecturer on Social and Behavioral Sciences
Center for Global Tobacco Control Research
Director, Center for Global Tobacco Control
Center for Global Tobacco Control Research
Harvard T.H. Chan School of Public Health
Dr. Rees is Director of the Center for Global Tobacco Control, whose mission is to reduce the global burden of tobacco-related death and disease through training, research, and the translation of science into public health policies and programs. He directs the Tobacco Research Laboratory at the Harvard Chan School, where the design and potential for dependence of tobacco products are assessed. Studies examine the impact of dependence potential on product use and individual risk, to inform policy and other interventions to control tobacco harms. Current research uses conventional and innovative strategies to evaluate new and novel tobacco products. Examples of these products include modified risk tobacco products such as e-cigarettes; reduced ignition propensity cigarettes; hookah (tobacco waterpipe); and novel smokeless tobacco products such as snus. Clinical research methods are used to evaluate the influence of tobacco product design features on consumer responses, and their role in promoting initiation or maintenance of use among targeted populations. Findings have been used to inform tobacco control policy, develop resources for communicating risks of tobacco products, and to enhance understanding of factors that contribute to tobacco dependence.
Other research involves development of strategies to reduce secondhand smoke (SHS) exposure in domestic environments, with a focus on evaluating interventions for reducing domestic SHS exposure among children. Dr. Rees also leads an NIH funded study which seeks to reduce secondhand smoke exposure among children from low income and racially/ethnically diverse backgrounds. This research utilizes the principles of community based participatory research (CBPR) to develop and evaluate a cognitive behavioral intervention to help caregivers maintain a smoke free home environment. He has conducted studies on SHS emissions of tobacco waterpipe, and SHS monitoring in indoor environments, including private homes and cars.
Dr. Rees' academic background is in health psychology (substance use and dependence), and he trained at the National Drug and Alcohol Research Centre at the University of New South Wales in Sydney, Australia, and did postdoctoral training through the National Institute on Drug Abuse. He has also published research on the role of cue reactivity in tobacco and alcohol abuse and dependence; and clinical trials on interventions for alcohol and cannabis dependence.
Liu J, Winickoff JP, Hanby E, Rees V, Emmons KM, Tan AS.
Drug Alcohol Depend. 2024 Jan 01. 254:111055. PMID: 38071894
Fix BV, Wackowski OA, Sharma A, Diaz D, Bansal-Travers M, Cummings KM, Rees VW, Hatsukami DK, O'Connor RJ.
Tob Use Insights. 2023. 16:1179173X231206042. PMID: 37842177
Liu J, Roberts J, Reynolds MJ, Hanby E, Gundersen DA, Winickoff JP, Rees VW, Emmons KM, Tan ASL.
Transl Behav Med. 2023 08 11. 13(8):589-600. PMID: 37084410
Theitler N, Rees VW, Peled-Raz M, Bitan M, Rosen LJ.
Isr J Health Policy Res. 2023 07 21. 12(1):25. PMID: 37480100
Liu J, Tan ASL, Winickoff JP, Rees VW.
Addict Behav. 2023 11. 146:107804. PMID: 37478525
Cummings KM, Roberson A, Carroll DM, Stepanov I, Hatsukami D, Rees VW, O'Connor RJ.
Tob Induc Dis. 2023. 21:85. PMID: 37360043
Rohde JA, Liu J, Rees VW.
J Health Commun. 2023 08 03. 28(8):487-497. PMID: 37341521
Gehlert S, Rees VW, Choi K, Jackson PD, Sheehan BE, Grucza RA, Paulson AC, Plunk AD.
Am J Prev Med. 2023 09. 65(3):512-516. PMID: 36871639
Buchanan EM, Lewis SC, Paris B, Forscher PS, Pavlacic JM, Beshears JE, Drexler SM, Gourdon-Kanhukamwe A, Mallik PR, Silan MAA, Miller JK, IJzerman H, Moshontz H, Beaudry JL, Suchow JW, Chartier CR, Coles NA, Sharifian M, Todsen AL, Levitan CA, Azevedo F, Legate N, Heller B, Rothman AJ, Dorison CA, Gill BP, Wang K, Rees VW, Gibbs N, Goldenberg A, Thi Nguyen TV, Gross JJ, Kaminski G, von Bastian CC, Paruzel-Czachura M, Mosannenzadeh F, Azouaghe S, Bran A, Ruiz-Fernandez S, Santos AC, Reggev N, Zickfeld JH, Akkas H, Pantazi M, Ropovik I, Korbmacher M, Arriaga P, Gjoneska B, Warmelink L, Alves SG, de Holanda Coelho GL, Stieger S, Schei V, Hanel PHP, Szaszi B, Fedotov M, Antfolk J, Marcu GM, Schrötter J, Kunst JR, Geiger SJ, Adetula A, Kocalar HE, Kielinska J, Kacmár P, Bokkour A, Galindo-Caballero OJ, Djamai I, Pöntinen SJ, Agesin BE, Jernsäther T, Urooj A, Rachev NR, Koptjevskaja-Tamm M, Kurfali M, Pit IL, Li R, Çoksan S, Dubrov D, Paltrow TE, Baník G, Korobova T, Studzinska A, Jiang X, Aruta JJBR, Vintr J, Chiu F, Kaliska L, Berkessel JB, Tümer M, Morales-Izquierdo S, Chuan-Peng H, Vezirian K, Rosa AD, Bialobrzeska O, Vasilev MR, Beitner J, Kácha O, Žuro B, Westerlund M, Nedelcheva-Datsova M, Findor A, Krupic D, Kowal M, Askelund AD, Pourafshari R, Ðordevic JM, Schmidt ND, Baklanova E, Szala A, Zakharov I, Vranka MA, Ihaya K, Grano C, Cellini N, Bialek M, Anton-Boicuk L, Dalgar I, Adigüzel A, Verharen JPH, Maturan PLG, Kassianos AP, Oliveira R, Cadek M, Adoric VC, Özdogru AA, Sverdrup TE, Aczel B, Zambrano D, Ahmed A, Tamnes CK, Yamada Y, Volz L, Sunami N, Suter L, Vieira L, Groyecka-Bernard A, Kamburidis JA, Reips UD, Harutyunyan M, Adetula GA, Allred TB, Barzykowski K, Antazo BG, Zsido AN, Šakan DD, Cyrus-Lai W, Ahlgren LP, Hruška M, Vega D, Manunta E, Mokady A, Capizzi M, Martoncik M, Say N, Filip K, Vilar R, Staniaszek K, Vdovic M, Adamkovic M, Johannes N, Hajdu N, Cohen N, Overkott C, Krupic D, Hubena B, Nilsonne G, Mioni G, Solorzano CS, Ishii T, Chen Z, Kushnir E, Karaarslan C, Ribeiro RR, Khaoudi A, Kossowska M, Bavolar J, Hoyer K, Roczniewska M, Karababa A, Becker M, Monteiro RP, Kunisato Y, Metin-Orta I, Adamus S, Kozma L, Czarnek G, Domurat A, Štrukelj E, Alvarez DS, Parzuchowski M, Massoni S, Czamanski-Cohen J, Pronizius E, Muchembled F, van Schie K, Saçakli A, Hristova E, Kuzminska AO, Charyate A, Bijlstra G, Afhami R, Majeed NM, Musser ED, Sirota M, Ross RM, Yeung SK, Papadatou-Pastou M, Foroni F, Almeida IAT, Grigoryev D, Lewis DMG, Holford DL, Janssen SMJ, Tatachari S, Batres C, Olofsson JK, Daches S, Belaus A, Pfuhl G, Corral-Frias NS, Sousa D, Röer JP, Isager PM, Godbersen H, Walczak RB, Van Doren N, Ren D, Gill T, Voracek M, DeBruine LM, Anne M, Ocovaj SB, Thomas AG, Arvanitis A, Ostermann T, Wolfe K, Arinze NC, Bundt C, Lamm C, Calin-Jageman RJ, Davis WE, Karekla M, Zorjan S, Jaremka LM, Uttley J, Hricova M, Koehn MA, Kiselnikova N, Bai H, Krafnick AJ, Balci BB, Ballantyne T, Lins S, Vally Z, Esteban-Serna C, Schmidt K, Macapagal PML, Szwed P, Zdybek PM, Moreau D, Collins WM, Joy-Gaba JA, Vilares I, Tran US, Boudesseul J, Albayrak-Aydemir N, Dixson BJW, Perillo JT, Ferreira A, Westgate EC, Aberson CL, Arinze AI, Jaeger B, Butt MM, Silva JR, Storage DS, Janak AP, Jiménez-Leal W, Soto JA, Sorokowska A, McCarthy R, Tullett AM, Frias-Armenta M, Ribeiro MFF, Hartanto A, Forbes PAG, Willis ML, Del Carmen Tejada R M, Torres AJO, Stephen ID, Vaidis DC, de la Rosa-Gómez A, Yu K, Sutherland CAM, Manavalan M, Behzadnia B, Urban J, Baskin E, McFall JP, Ogbonnaya CE, Fu CHY, Rahal RM, Ndukaihe ILG, Hostler TJ, Kappes HB, Sorokowski P, Khosla M, Lazarevic LB, Eudave L, Vilsmeier JK, Luis EO, Muda R, Agadullina E, Cárcamo RA, Reeck C, Anjum G, Venegas MCT, Misiak M, Ryan RM, Nock NL, Travaglino GA, Mensink MC, Feldman G, Wichman AL, Chou W, Ziano I, Seehuus M, Chopik WJ, Kung FYH, Carpentier J, Vaughn LA, Du H, Xiao Q, Lima TJS, Noone C, Onie S, Verbruggen F, Radtke T, Primbs MA.
Sci Data. 2023 02 11. 10(1):87. PMID: 36774440
Carroll DM, Tessier K, Luo X, Stepanov IS, Shields PG, O'Connor R, Rees VW, Cummings M, Bickel W, Hatsukami D.
Tob Control. 2023 Jan 23. PMID: 36690447
Experts from Harvard T.H. Chan School of Public Health discuss the public health implications of the FDA's actions.
The U.S. Food and Drug Administration (FDA) has proposed new rules that ban the manufacture and sale of menthol cigarettes and all flavored cigars.
Three Harvard Chan School experts weigh in on the FDA’s decision to authorize a set of three e-cigarette products for sale in the U.S. for the first time.
December 3, 2020 – Tobacco use has been declining for years in the U.S., but the COVID-19 pandemic threatens that progress. Vaughan Rees, director of the Center for Global Tobacco Control, discussed how the stress of the pandemic…
Tobacco pouches are less harmful than cigarettes—somewhat, according to the U.S. Food and Drug Administration (FDA). The FDA announced on October 22, 2019 that the pouches, sold by a Swedish company, are now officially classified as reduced risk…